Application of high-sensitivity troponin in suspected myocardial infarction

Neumann, Johannes T., Twerenbold, Raphael, Ojeda, Francisco, Sorensen, Nils A., Chapman, Andrew R., Shah, Anoop S.V., Anand, Atul, Boeddinghaus, Jasper, Nestelberger, Thomas, Badertscher, Patrick, Mokhtari, Arash, Pickering, John W., Troughton, Richard W., , , Mueller-Hennessen, Matthias, Gori, Tommaso, Jernberg, Tomas, Morris, Niall, Liebetrau, Christoph, Hamm, Christian, Katus, Hugo A., Münzel, Thomas, Landmesser, Ulf, Salomaa, Veikko, Iacoviello, Licia, Ferrario, Marco M., Giampaoli, Simona, Kee, Frank, Thorand, Barbara, Peters, Annette, Borchini, Rossana, Jørgensen, Torben, Söderberg, Stefan, Sans, Susana, Tunstall-Pedoe, Hugh, Kuulasmaa, Kari, Renné, Thomas, Lackner, Karl J., Worster, Andrew, Body, Richard, Ekelund, Ulf, Kavsak, Peter A., Keller, Till, Lindahl, Bertil, Wild, Philipp, Giannitsis, Evangelos, Than, Martin, , Mills, Nicholas L., Mueller, Christian, Zeller, Tanja, Westermann, Dirk, & Blankenberg, Stefan (2019) Application of high-sensitivity troponin in suspected myocardial infarction. The New England Journal of Medicine, 380(26), pp. 2529-2540.

Free-to-read version at publisher website

Description

BACKGROUND: Data regarding high-sensitivity troponin concentrations in patients presenting to the emergency department with symptoms suggestive of myocardial infarction may be useful in determining the probability of myocardial infarction and subsequent 30-day outcomes.

METHODS: In 15 international cohorts of patients presenting to the emergency department with symptoms suggestive of myocardial infarction, we determined the concentrations of high-sensitivity troponin I or high-sensitivity troponin T at presentation and after early or late serial sampling. The diagnostic and prognostic performance of multiple high-sensitivity troponin cutoff combinations was assessed with the use of a derivation-validation design. A risk-assessment tool that was based on these data was developed to estimate the risk of index myocardial infarction and of subsequent myocardial infarction or death at 30 days.

RESULTS: Among 22,651 patients (9604 in the derivation data set and 13,047 in the validation data set), the prevalence of myocardial infarction was 15.3%. Lower high-sensitivity troponin concentrations at presentation and smaller absolute changes during serial sampling were associated with a lower likelihood of myocardial infarction and a lower short-term risk of cardiovascular events. For example, high-sensitivity troponin I concentrations of less than 6 ng per liter and an absolute change of less than 4 ng per liter after 45 to 120 minutes (early serial sampling) resulted in a negative predictive value of 99.5% for myocardial infarction, with an associated 30-day risk of subsequent myocardial infarction or death of 0.2%; a total of 56.5% of the patients would be classified as being at low risk. These findings were confirmed in an external validation data set.

CONCLUSIONS: A risk-assessment tool, which we developed to integrate the high-sensitivity troponin I or troponin T concentration at emergency department presentation, its dynamic change during serial sampling, and the time between the obtaining of samples, was used to estimate the probability of myocardial infarction on emergency department presentation and 30-day outcomes.

Impact and interest:

229 citations in Scopus
182 citations in Web of Science®
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

Full-text downloads:

397 since deposited on 17 Mar 2020
70 in the past twelve months

Full-text downloads displays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.

ID Code: 197643
Item Type: Contribution to Journal (Journal Article)
Refereed: Yes
ORCID iD:
Greenslade, Jaimiorcid.org/0000-0002-6970-5573
Parsonage, Williamorcid.org/0000-0002-0223-5378
Measurements or Duration: 12 pages
DOI: 10.1056/NEJMoa1803377
ISSN: 0028-4793
Pure ID: 46534192
Divisions: Past > QUT Faculties & Divisions > Faculty of Health
Past > Institutes > Institute of Health and Biomedical Innovation
Funding Information: Supported by the German Center for Cardiovascular Research (DZHK).
Copyright Owner: Massachusetts Medical Society
Copyright Statement: This work is covered by copyright. Unless the document is being made available under a Creative Commons Licence, you must assume that re-use is limited to personal use and that permission from the copyright owner must be obtained for all other uses. If the document is available under a Creative Commons License (or other specified license) then refer to the Licence for details of permitted re-use. It is a condition of access that users recognise and abide by the legal requirements associated with these rights. If you believe that this work infringes copyright please provide details by email to qut.copyright@qut.edu.au
Deposited On: 17 Mar 2020 01:01
Last Modified: 08 Aug 2024 23:46